Dosimetric benefits of dynamic conformal arc therapy-combined with active breath-hold in lung stereotactic body radiotherapy

Lee, Soyoung; Lee, Danny; Verma, Vivek; Waters, Danielle; Oh, Seungjong; Colonias, Athanasios; Wegner, Rodney E.; Pavord, D; Coopey, Bryan C.; Fuhrer, Russell; Sohn, Jason W.

doi:10.1016/j.meddos.2021.08.004

Cited by 2 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stereotactic body radiation therapy (SBRT) is a well-established treatment technique for patients with inoperable small NSCLC (<5 cm). 6,7 The technique enables the conformal delivery of high doses of radiation (i.e., to the target, resulting in increased local tumour control (>80% at 2 years) while maintaining a relatively low toxicity rate. 6,[8][9][10] For bulky NSCLC, conventional hyper-fractionated scheme in addition to chemotherapy is commonly used.…”

Section: Introductionmentioning

confidence: 99%

“…6,7 The technique enables the conformal delivery of high doses of radiation (i.e., to the target, resulting in increased local tumour control (>80% at 2 years) while maintaining a relatively low toxicity rate. 6,[8][9][10] For bulky NSCLC, conventional hyper-fractionated scheme in addition to chemotherapy is commonly used. [11][12][13] Concurrent radiation therapy has been delivered using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT) or volumetric-modulated arc therapy (VMAT).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Dosimetric evaluation of VMAT treatment plans for patients with stage IIB or III non-small cell lung carcinomas

et al. 2023

View full text Add to dashboard Cite

Introduction: Volumetric-modulated arc therapy (VMAT) has emerged as a promising radiation treatment technique. One of the challenges in VMAT planning for lung carcinoma is the lack of consistency among different institutions with respect to what is considered an acceptable treatment plan in terms of target coverage and doses to the organs at risk (OAR). Additionally, the accuracy of dose calculations in the presence of heterogeneous medium (i.e. air) is another challenge in lung VMAT planning. Our objective is to develop an institutional criteria for non-stereotactic body radiotherapy (non-SBRT) lung treatment plans by evaluating the dosimetric impact of plan normalisation and dose calculation algorithms, including the Anisotropic Analytical Algorithm (AAA), AcurosXB (AXB) and Monte Carlo (MC) simulation, on VMAT plans for non-small cell lung cancer (NSCLC). Methods: The CT dataset of 20 patients with NSCLC was randomly selected to ensure a spectrum of target sizes and locations. All treatment planning was accomplished with 2–3 VMAT arcs and a prescription of 60 Gy in 30 fractions. Two plan normalisation methods were employed: (i) planning target volume (PTV) V100% = 95% and (ii) PTV V95% = 95%. Results: All three dose calculation algorithms revealed heterogeneous and conformal plans irrespective of plan normalisations. The PTV and OARs dose–volume constraints were met using both normalisation methods. However, we observed that AAA overestimated the minimum PTV doses by 2–5% regardless of plan normalisation. The mean PTV-V100% was lower for AAA in comparison with AXB and MC algorithms. Conclusions: VMAT is an effective radiotherapy technique for achieving greater target dose conformity, heterogeneity and dose fall-off from the PTV for the treatment of NSCLC. The results of this study can provide the basis for the development of local plan acceptability criteria for NSCLC VMAT plans, and the clinical implementation can be achieved with minimal or no imposition on resources and time constraints. Occasionally, plan normalisation of PTV-V95% = 95% may be required to ensure that the OAR dose tolerances are not exceeded.

show abstract